Technology
Platform
GliaX™
GliaPharm has established a proprietary drug discovery platform, GliaX™, centered on glial cells activity and brain metabolism.
Through this platform, the company is developing its pipeline program to establish a new class of agents for neuroprotection and maintenance of cognitive functions.
GliaX™ also serves collaboration with academic and industrial partners.
Specialized
Glial Assays
Cellular
Systems
Translational
In vivo Models
Brain metabolism
Morphology & activity
Cellular inflammation
Signaling cascades
Primary Brain cells
Human induced pluripotent stem cells (iPSCs)
Brain organoids with microelectrode array (MEA)
Neuron-Glia co-cultures
Intracerebral biosensors
EEG, FDG-PET, MRI
In vivo disease models
Harnessing the Power
of Glia
assays
Brain metabolism
Cellular Viability
Cellular inflammation
Signalling cascades
assays
Brain cell cultures
Human iPSC model cultures
In vivo brain metabolite analysis
Chemistry
Al-driven target modelling
In vitro target identification
Small molecule design
characterisation
technologies
Brain organoids
Digital Holography Microscopy
Behavioural
Tests
In-house behavioural capability in multiple rodent models
Translational
biomarkers
FDG PET/ MRI
EEG
Cerebrospinal Fluid (CSF)
